🇪🇺 sasanlimab in European Union

sasanlimab (sasanlimab) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/006641
  • Local brand name: Zumrad
  • Status: application withdrawn

sasanlimab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in European Union

Frequently asked questions

Is sasanlimab approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for sasanlimab in European Union?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.